Potential link between excess added sugar intake and ectopic fat: A systematic review of randomized controlled trials

Nutrition Reviews

Volumn 74, Issue 1, 2016, Pages 18-32

  Ma, Jiantao ^a   Karlsen, Micaela C ^a   Chung, Mei ^b   Jacques, Paul F ^a   Saltzman, Edward ^a   Smith, Caren E ^a   Fox, Caroline S ^c,d   McKeown, Nicola M ^a  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FRAMINGHAM HEART STUDY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Added sugar; Ectopic fat depots; Liver fat; Muscle fat; Visceral adipose tissue

Indexed keywords

CARBOHYDRATE; FRUCTOSE; PALATINOSE; SUCROSE; MONOSACCHARIDE; SUGAR INTAKE;

ARTICLE; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CIRCULATION; COCHRANE LIBRARY; DATA BASE; EVIDENCE BASED MEDICINE; HUMAN; INTRAABDOMINAL FAT; LIPID STORAGE; MACRONUTRIENT; MEDLINE; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUGAR INTAKE; SYSTEMATIC REVIEW; ADIPOSE TISSUE; ADMINISTRATION AND DOSAGE; CHORISTOMA; DIET; FEEDING BEHAVIOR; LIVER; METABOLISM; MUSCLE; PHARMACOLOGY;

ADIPOSE TISSUE; CHORISTOMA; DIET; DIETARY SUCROSE; ENERGY INTAKE; FEEDING BEHAVIOR; HUMANS; LIVER; MONOSACCHARIDES; MUSCLES;

EID: 84960083384     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1093/nutrit/nuv047     Document Type: Article

References (58)

1. Despres JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126:1301-1313.
2. Britton KA, Fox CS. Ectopic fat depots and cardiovascular disease. Circulation. 2011;124:e837-e841.
3. Tappy L, Le KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 2010;90:23-46.
4. Nseir W, Nassar F, Assy N. Soft drinks consumption and nonalcoholic fatty liver disease. World J Gastroenterol. 2010;16:2579-2588.
5. Lustig RH. Fructose: metabolic, hedonic, and societal parallels with ethanol. J Am Diet Assoc. 2010;110:1307-1321.
6. Yilmaz Y. Review article: fructose in non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2012;35:1135-1144.
7. Chiu S, Sievenpiper JL, de Souza RJ, et al. Effect of fructose on markers of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr. 2014;68:416-423.
8. Welsh JA, Sharma A, Abramson JL, et al. Caloric sweetener consumption and dyslipidemia among US adults. JAMA. 2010;303:1490-1497.
9. US Department of Agriculture and US Department of Health and Human Services. Dietary Guidelines for Americans, 2010. 7th ed. Washington, DC: US Government Printing Office; 2010.
10. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. London: The Cochrane Collaboration; 2011. www. cochrane-handbook.org. Updated March 2011. Accessed October 1, 2014.
11. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions:explanation and elaboration. PLoS Med. 2009;6:e1000100. doi:10.1371/ journal.pmed.1000100.
12. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi:10.1136/bmj.b2535.
13. Maersk M, Belza A, Stodkilde-Jorgensen H, et al. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr. 2012;95:283-289.
14. Jin R, Welsh JA, Le NA, et al. Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. Nutrients. 2014;6:3187-3201.
15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
16. Leclercq I, Horsmans Y, Desager JP, et al. Dietary restriction of energy and sugar results in a reduction in human cytochrome P450 2E1 activity. Br J Nutr. 1999;82:257-262.
17. Volynets V, Machann J, Kuper MA, et al. A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study. Eur J Nutr. 2013;52:527-535.
18. Sevastianova K, Santos A, Kotronen A, et al. Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am J Clin Nutr. 2012;96:727-734.
19. Le KA, Faeh D, Stettler R, et al. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am J Clin Nutr. 2006;84:1374-1379.
20. Abid A, Taha O, Nseir W, et al. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol. 2009;51:918-924.
21. Assy N, Nasser G, Kamayse I, et al. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol. 2008;22:811-816.
22. Ouyang X, Cirillo P, Sautin Y, et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol. 2008;48:993-999.
23. Thuy S, Ladurner R, Volynets V, et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr. 2008;138:1452-1455.
24. Volynets V, Kuper MA, Strahl S, et al. Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD). Dig Dis Sci. 2012;57:1932-1941.
25. Odegaard AO, Choh AC, Czerwinski SA, et al. Sugar-sweetened and diet beverages in relation to visceral adipose tissue. Obesity. 2012;20:689-691.
26. Davis JN, Le KA, Walker RW, et al. Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption. Am J Clin Nutr. 2010;92:1522-1527.
27. Pollock NK, Bundy V, Kanto W, et al. Greater fructose consumption is associated with cardiometabolic risk markers and visceral adiposity in adolescents. J Nutr. 2012;142:251-257.
28. Petta S, Marchesini G, Caracausi L, et al. Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J Hepatol. 2013;59:1169-1176.
29. Yamori Y, Mori M, Mori H, et al. Japanese perspective on reduction in lifestyle disease risk in immigrant Japanese Brazilians: a double-blind, placebo-controlled intervention study on palatinose. Clin Exp Pharmacol Physiol. 2007;34(suppl 1):S5-S7.
30. Okuno M, Kim MK, Mizu M, et al. Palatinose-blended sugar compared with sucrose:different effects on insulin sensitivity after 12 weeks supplementation in sedentary adults. Int J Food Sci Nutr. 2010;61:643-651.
31. Koopman KE, Caan MW, Nederveen AJ, et al. Hypercaloric diets with increased meal frequency, but not meal size, increase intrahepatic triglycerides: a randomized controlled trial. Hepatology. 2014;60:545-553.
32. Lecoultre V, Carrel G, Egli L, et al. Coffee consumption attenuates short-term fructose-induced liver insulin resistance in healthy men. Am J Clin Nutr. 2014;99:268-275.
33. Theytaz F, Noguchi Y, Egli L, et al. Effects of supplementation with essential amino acids on intrahepatic lipid concentrations during fructose overfeeding in humans. Am J Clin Nutr. 2012;96:1008-1016.
34. Ngo Sock ET, Le KA, Ith M, et al. Effects of a short-term overfeeding with fructose or glucose in healthy young males. Br J Nutr. 2010;103:939-943.
35. Le KA, Ith M, Kreis R, et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr. 2009;89:1760-1765.
36. Hasson RE, Adam TC, Davis JN, et al. Randomized controlled trial to improve adiposity, inflammation, and insulin resistance in obese African-American and Latino youth. Obesity. 2012;20:811-818.
37. Bravo S, Lowndes J, Sinnett S, et al. Consumption of sucrose and high-fructose corn syrup does not increase liver fat or ectopic fat deposition in muscles. Appl Physiol Nutr Metab. 2013;38:681-688.
38. Johnston RD, Stephenson MC, Crossland H, et al. No difference between highfructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men. Gastroenterology. 2013;145:1016-1025.
39. Lecoultre V, Egli L, Carrel G, et al. Effects of fructose and glucose overfeeding on hepatic insulin sensitivity and intrahepatic lipids in healthy humans. Obesity. 2013;21:782-785.
40. Silbernagel G, Machann J, Unmuth S, et al. Effects of 4-week very-high-fructose/ glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial. Br J Nutr. 2011;106:79-86.
41. Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009;119:1322-1334.
42. Sobrecases H, Le KA, Bortolotti M, et al. Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men. Diabetes Metab. 2010;36:244-246.
43. Lanaspa MA, Ishimoto T, Li N, et al. Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat Commu. 2013;4:2434. doi:10.1038/ncomms3434.
44. Bortolotti M, Kreis R, Debard C, et al. High protein intake reduces intrahepatocellular lipid deposition in humans. Am J Clin Nutr. 2009;90:1002-1010.
45. Heilbronn L, Smith SR, Ravussin E. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord. 2004;28(suppl 4):S12-S21.
46. Fox CS, Liu Y, White CC, et al. Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women. PLoS Genet. 2012;8:e1002695. doi:10.1371/journal.pgen.1002695.
47. Speliotes EK, Yerges-Armstrong LM, Wu J, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 2011;7:e1001324. doi:10.1371/ journal.pgen.1001324.
48. Tchernof A, Despres JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93:359-404.
49. Badin PM, Louche K, Mairal A, et al. Altered skeletal muscle lipase expression and activity contribute to insulin resistance in humans. Diabetes. 2011;60:1734-1742.
50. Fabbrini E, Magkos F, Mohammed BS, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A. 2009;106:15430-15435.
51. Fried SK, Russell CD, Grauso NL, et al. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest. 1993;92:2191-2198.
52. Roncal-Jimenez CA, Lanaspa MA, Rivard CJ, et al. Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake. Metabolism. 2011;60:1259-1270.
53. Pagliassotti MJ, Prach PA, Koppenhafer TA, et al. Changes in insulin action, triglycerides, and lipid composition during sucrose feeding in rats. Am J Physiol. 1996;271(5 pt 2):R1319-R1326.
54. Sanchez-Lozada LG, Mu W, Roncal C, et al. Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver. Eur J Nutr. 2010;49:1-9.
55. Thirunavukkarasu V, Anitha Nandhini AT, Anuradha CV. Cardiac lipids and antioxidant status in high fructose rats and the effect of alpha-lipoic acid. Nutr Metab Cardiovasc Dis. 2004;14:351-357.
56. Axelsen LN, Lademann JB, Petersen JS, et al. Cardiac and metabolic changes in long-term high fructose-fat fed rats with severe obesity and extensive intramyocardial lipid accumulation. Am J Physiol Regul Integr Comp Physiol. 2010;298:R1560-R1570.
57. Fullenkamp AM, Bell LN, Robbins RD, et al. Effect of different obesogenic diets on pancreatic histology in Ossabaw miniature swine. Pancreas. 2011;40:438-443.
58. Marriott BP, Cole N, Lee E. National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J Nutr. 2009;139:1228S-1235S.